Integral Somatic Regulation Under Clinical Pressure

A Clinician-Leader Cohort

Last updated: May 2026

This is the cohort for the level of clinical leadership most exposed to the work and least supported by it. Charge nurses, utilization-management supervisors, clinical pharmacist leads at PBMs and specialty pharmacies, MBHO clinical directors, and department chairs carry the full moral and regulatory weight of U.S. healthcare — and are structurally isolated from the peer support and regulation practice that could hold it. A 6-month cohort, principal-delivered by Thomas G. Goddard, JD, PhD, CCEP.

What This Cohort Is

Integral Somatic Regulation Under Clinical Pressure is a 6-month group cohort for 10–15 clinical leaders — charge nurses, medical directors, department chairs, UM directors, and pharmacy directors — that builds the integrated regulation, relational, and meaning skills that determine team psychological safety. Delivered by Thomas G. Goddard, JD, PhD, CCEP. The cohort is built on the premise that the most consequential thing a clinical leader does every day is regulate, or fail to regulate, under pressure. What state they are in when they walk into a team meeting. What state they are in when they deliver a denial decision. What state they are in when a staff member tries to raise a concern and the leader's nervous system is already carrying the load of three prior conversations. Psychological safety on clinical teams — the single strongest predictor of error reporting, quality outcomes, and staff retention — runs directly through the regulation capacity of the leader who sets the field.

The cohort builds that capacity over six months, not six hours. It treats the body and the emotional toll of the role as the actual substrate of clinical leadership, not as personal wellness issues participants should address on their own time.

What Participants Develop

  • Somatic awareness under operational load — the capacity to recognize their own autonomic state in real time and work with it rather than be driven by it during high-stakes clinical and team interactions.
  • Regulation practices calibrated to the clinical-leader schedule — not meditation app suggestions but practices that fit a charge nurse's 12-hour shift, a UM supervisor's prior-auth queue, a clinical director's afternoon of back-to-back escalations.
  • The skills to hold team-level psychological safety — specifically the relational behaviors (repair, acknowledgment, structured reflection) that Edmondson's research identifies as the mechanism through which leaders create or destroy the conditions for staff to speak up.
  • A named framework for moral injury at the unit level — the structural understanding of why this work produces the specific kind of suffering it does, which is different from burnout, and what changes at the leadership level when it is named rather than absorbed silently.
  • Peer cohort as an institutional response to isolation — clinical leaders at this level are typically the most isolated people in their organizations: below the executives who have access to coaching and above the staff who have peer networks. The cohort provides the peer accountability structure the role otherwise does not.

What This Cohort Does Not Claim

The cohort is not a clinical intervention for any individual participant. It does not diagnose or treat compassion fatigue, post-traumatic stress, or any clinical condition. It does not promise reductions in staff turnover, patient safety events, or regulatory citations — the causal chain from leadership regulation capacity to those outcomes is empirically real but not closed enough to commit to in scope. It is a leadership development engagement. The work it does is at the level of the leader and the unit; what the organization does with that is the organization's to decide.

The Science Behind It

The body layer rests on Stephen Porges's polyvagal theory of autonomic regulation (Porges, Psychophysiology, 1995; The Polyvagal Theory, 2011). The theory establishes that the human nervous system operates across three functional states — ventral vagal (social engagement, regulated capacity), sympathetic (mobilization, threat response), and dorsal vagal (shutdown, collapse) — and that which state a leader is operating from is not a mood or a character trait but a physiological condition that can be recognized and worked with. Clinical leaders in U.S. healthcare in 2026 are operating under sustained sympathetic activation: prior-auth backlogs, denial-cascade workflows, regulatory-change cadence, and moral-injury load all function as chronic nervous system activators. The cohort begins at this substrate.

The heart layer — emotional toll. The compassion-fatigue and moral injury literature is specific about what happens at the unit-leadership level. Stamm's Professional Quality of Life scale (ProQOL, 2009) distinguishes compassion satisfaction from compassion fatigue and secondary traumatic stress — the clinical leader who carries the team's pain without a structural container for their own is not experiencing individual weakness; they are experiencing a predictable consequence of role design. Moral injury — the wound that occurs when a person is compelled to act against their moral code, or witnesses such action without institutional acknowledgment — is the more precise term for what UM supervisors, prior-auth team leads, and MBHO clinical directors describe when they say they are burning out. The cohort names this accurately.

The heart layer — relational coherence. Amy Edmondson's psychological safety research with clinical teams (Edmondson, Administrative Science Quarterly, 1999; Journal of Management Studies, 2003) established that team psychological safety — the shared belief that the team is safe for interpersonal risk-taking — is the strongest predictor of error reporting, quality, and learning in clinical settings. The leader is the primary determinant of that field. The Schwartz Center Rounds evidence base (Lown and Manning, Academic Medicine, 2010) demonstrates that structured peer reflection for clinical professionals reduces isolation and improves the relational quality of the care environment. The cohort applies both lineages at the unit-leadership level.

The mind layer. Trockel et al.'s organizational-factor analysis found that approximately 70% of physician burnout variance is explained by organizational and structural factors, not individual-level ones (Trockel et al., JAMA Internal Medicine, 2018). Maslach's burnout research (Maslach Burnout Inventory, 1981) provides validated measurement. The cohort uses both to contextualize participant experience at the structural level — to name what the institution is producing, not just what the individual is carrying.

Who Belongs in This Cohort

The cohort is calibrated to clinical leaders who carry direct accountability for a team operating under regulatory and moral load. The primary sponsor is typically the CNO, CMO, Chief Behavioral Health Officer, or Chief Pharmacy Officer purchasing on behalf of their clinical-leader tier. Managed care organizations lead the segment read — the regulatory-churn and prior-authorization load facing clinical leadership in these organizations is the highest-concentration friction site the cohort addresses.

Clinician-leader regulation is the binding constraint on team performance. RN turnover stands at 17.6% with hospital turnover at 18.5% (NSI 2026). Global nurse burnout prevalence runs 30–60% with 61% of nurses globally reporting anxiety, depression, or burnout (JoyMetrics 2026). 55% of US healthcare workers are considering leaving the field within twelve months (National Council on Behavioral Health). US physician suicide remains at 300–400 per year, with female physicians' suicide risk 250–400% higher than non-medical peers (AMA/AFSP). Healthcare worker exposure to workplace violence runs at 61.9% any-form and 24.4% physical violence in the past year (NCBI WMA review). The clinician-leader's regulation capacity is what determines whether the team can function under these conditions or fractures under them.

  • Managed behavioral healthcare organizations — utilization-review supervisors, intake clinical directors, and authorization team leads doing high-volume, high-stakes determinations in a sector with documented workforce-supply collapse and acute moral-injury load.
  • Health plan utilization-management and prior-authorization leadership — UM nurse supervisors and prior-auth team leads operating under CMS-0057-F implementation timelines, compressed decision windows, and the sustained activation that comes with denial work against medical-necessity judgments.
  • PBM clinical pharmacist supervisors — clinical pharmacist leads and prior-authorization supervisors at pharmacy benefit managers carrying step-therapy enforcement, drug-coverage determination load, and the regulatory-churn of interoperability and prior-auth rule extension.
  • Specialty pharmacy intake supervisors and pharmacists-in-charge — clinical staff and supervisors at specialty pharmacies operating under reimbursement adversity (copay-accumulator programs, manufacturer-assistance unwinding, payer-mix complexity) and the moral weight of patient-access determinations.
  • MCO care-management and compliance team leads — care-management supervisors and compliance officers carrying the cadence of state-mandate change, Medicaid-health-plan regulatory rhythms, and member-services escalation load.
  • Hospital charge nurses and department-level clinical leaders — charge nurses, medical directors, and department chairs in hospital systems and health systems where the mid-level clinical-leadership tier carries the relay between executive direction and direct-care staff and is structurally unsupported by either.
  • Behavioral health clinic supervisors and FQHC clinical directors — clinical supervisors at behavioral health organizations, federally qualified health centers, and community mental health centers where the compassion-fatigue load is highest and institutional support for it is thinnest.

The 6-Month Program Structure

The cohort runs on a bi-weekly cadence across 24 weeks. The structure is not a curriculum delivered to participants — it is a container in which participants do the actual work of regulation, with the principal and with each other, against the real conditions of their roles.

The arc across the 6 months is designed. The first two months concentrate on somatic awareness: recognizing autonomic state, naming what is happening in the body during high-stakes interactions, and beginning to distinguish threat-state reactivity from ventral-vagal regulated response. Months three and four shift toward team-level application: the psychological safety mechanics, repair practices, and relational attunement that determine whether the leader can hold the field their unit needs. Months five and six address moral injury at depth — the institutional naming of what the role produces, the boundary between absorbing and carrying, and what sustainable leadership looks like when the work itself is morally costly. The midpoint retreat and each 1:1 session calibrate the individual arc inside this collective one.

Bi-Weekly Group Sessions (12 sessions, 90 minutes each)

Virtual sessions with the full cohort. Each session opens with a brief somatic check-in — a structured practice, not a wellness warm-up — followed by a themed focus (autonomic awareness; moral injury and its distinction from burnout; team psychological safety mechanics; repair and relational re-entry after rupture; leading in dorsal-vagal collapse; regulation under specific operational load types). Sessions include structured peer exchange and close with a between-session practice commitment. The format is adapted from Schwartz Center Rounds for clinical leaders: peer reflection as a clinical skill, not a soft add-on.

Bi-Monthly 1:1 Coaching (3 sessions, 60 minutes each)

Individual sessions with the principal — one at the cohort opening, one at the midpoint, one at the close. These sessions address the participant's specific role context, the regulation challenges particular to their unit and organization, and the personal dimensions of moral injury and emotional load that are not appropriate for the group container.

Midpoint In-Person Retreat (where geography supports it)

A full-day in-person session for the cohort at the 3-month mark. The retreat creates the conditions for somatic and relational work that video cannot fully hold: embodied practices, peer accountability conversations, and a structured reflection on what has changed and what has not across the first half of the cohort. Geography-distributed cohorts work through an extended virtual day at the same juncture.

Team-Level Intervention (each participant's direct unit)

Each participant's direct team receives one structured intervention across the 6-month period: an observation of a team interaction or workflow moment; a facilitated 60-90 minute team session grounded in psychological safety and regulation practice for the unit's specific operational context; and a debrief with the participant-leader on what they observed and what they want to carry forward. The intervention connects what the leader is developing in the cohort to the actual relational field of their team — the place where it either lands or doesn't.

Post-Cohort 60-Day Follow-Up

A single 60-minute individual session at the 8-month mark. The session is diagnostic: what held, what collapsed under load, what the participant wants to build next. The sponsoring organization receives an aggregate summary. No individual content is reported back. For participants who want to extend the work, an optional ongoing peer circle is available — lower-intensity, scoped separately, without a default renewal assumption.

What Participants Receive

  • Pre-cohort individual baseline — a physiological and psychological-safety baseline using the ProQOL (compassion satisfaction, compassion fatigue, secondary traumatic stress) and a validated psychological-safety scale, administered individually before the cohort opens. Used to track change and to calibrate the principal's 1:1 approach to each participant.
  • 12 bi-weekly group sessions — 90 minutes each, virtual, with structured somatic practice, peer exchange, and between-session commitments.
  • 3 bi-monthly 1:1 coaching sessions — 60 minutes each, individual, with the principal.
  • Midpoint in-person retreat — full day where geography supports it; extended virtual day for distributed cohorts.
  • Team-level intervention — observation, facilitated team session, and debrief with each participant's direct unit.
  • Post-cohort 60-day follow-up — individual session at 8 months; aggregate summary to the sponsoring organization.

Why This Differs from Wellness Apps, EAP, and Executive Leadership Cohorts

Wellness Apps Address Individuals, Not Clinical Leaders Under Institutional Load

BetterUp, Lyra, Spring Health, Calm, and similar platforms address individual self-report through app-mediated content and coaching. The evidence base for these platforms in reducing moral injury at the unit-leadership level is thin. None operates at the level of the team field — they cannot reach the psychological safety of the unit the leader manages, and they are not calibrated to the regulatory and moral load that defines clinical leadership in managed care, behavioral health, or specialty pharmacy in 2026.

EAP Is a Referral Pathway, Not a Leadership Development Container

The Employee Assistance Program is a benefit for individual employees in distress — appropriately so. It is not a structured development container for clinical leaders. It does not address the relational and team-level dimensions of the role. EAP counselors are not equipped to hold the specific moral-injury load of a UM supervisor who has spent six months under CMS-0057-F implementation pressure, nor should they be. The cohort and the EAP address different layers and do not substitute for each other.

Executive Leadership Cohorts Are Not Built for This Level or This Load

Leadership development programs calibrated to the C-suite — and IHS offers one — are built for a different set of pressures, a different price point, and a different institutional relationship to authority. This cohort is built for clinical leaders who are not executives, who carry the full weight of the clinical and regulatory environment at the unit level, and who are typically outside the reach of organizational investment in development. The register, the content, and the price point are designed for institutional sponsorship at the clinical-leadership tier.

Why IHS for This Cohort

The cohort is principal-delivered. The credential combination behind it is not assembled elsewhere in U.S. healthcare consulting.

About the Principal

Thomas G. Goddard, JD, PhD, CCEP — CEO of Integral Healthcare Solutions; Founding Member of the Integral Institute of Medicine.

Forty-plus years across U.S. healthcare regulation, policy, and organizational practice: Special Assistant to a U.S. governor on Medicaid policy; Counsel for Government and Media Relations at the National Association of Insurance Commissioners; VP and General Counsel of NYLCare Health Plans of the Mid-Atlantic (500,000 members); COO and General Counsel of URAC; Senior Consultant at Booz Allen Hamilton; twenty-four years as CEO of Integral Healthcare Solutions. Faculty appointments at George Mason University School of Management and Seton Hall Law School's Healthcare Compliance Certification Program.

PhD in Industrial-Organizational Psychology (George Mason University) — the measurement and validation discipline that grounds the pre-cohort baseline, the ProQOL, and the cohort's structural rigor. Juris Doctor (University of Arizona). Certified Core Energetics Practitioner (Institute of Core Energetics) — the somatic and relational training that makes the body layer of this cohort more than a wellness gloss. Expert witness in Wit v. United Behavioral Health and seven other federal and state cases. The regulatory career means that when a UM supervisor describes what it feels like to deny a claim they believe should be approved, the principal understands the institutional machinery producing that moment from the inside — not from a wellness-consulting distance.

Frequently Asked Questions

How large is the cohort?

Ten to fifteen clinical leaders per cohort. Small enough for genuine peer accountability and real relational work across six months; large enough to mirror the cross-functional isolation clinical leaders at this level actually carry.

Who pays — the organization or the participant?

The cohort is designed to be sponsored by the organization — CNO, CMO, Chief Behavioral Health Officer, or Chief Pharmacy Officer — on behalf of a cohort of their clinical leaders. Individual self-pay is possible but the engagement model and price point are calibrated to institutional sponsorship.

What is the time commitment for participants?

Bi-weekly 90-minute group sessions (12 sessions across 6 months); bi-monthly 60-minute 1:1 coaching (3 sessions); one in-person retreat day at midpoint where geography supports it; one team-level intervention with the participant's direct unit (approximately 3-4 hours across two interactions). Total principal-contact time is approximately 22-26 hours over 6 months.

Is cohort content confidential from the sponsoring organization?

Yes. What participants share in group sessions and 1:1 coaching is confidential to the cohort and principal — not reported back to the sponsoring organization. The organization receives aggregate cohort-level observations at midpoint and post-cohort; no individual content is ever reported. Confidentiality terms are documented in the engagement letter before the cohort opens.

What does the team-level intervention cover?

Each participant's direct unit receives one structured intervention: an observation period (shadow of a team interaction or workflow moment), a facilitated 60-90 minute team session grounded in psychological safety and regulation practice for the unit's specific operational context, and a debrief with the participant-leader. It does not disclose individual cohort content. Grounded in Edmondson's psychological safety framework and Schwartz Center Rounds methodology adapted for unit-level clinical leadership.

What is the evidence base?

Porges's polyvagal theory (The Polyvagal Theory, 2011); Edmondson's psychological safety research (Administrative Science Quarterly, 1999; Journal of Management Studies, 2003); Schwartz Center Rounds (Lown and Manning, Academic Medicine, 2010); Stamm's Professional Quality of Life scale (ProQOL, 2009); Maslach Burnout Inventory (1981); Trockel et al. on organizational factors and burnout variance (JAMA Internal Medicine, 2018).

Can staff not currently in a formal leadership role participate?

The cohort is calibrated to clinical leaders carrying direct team accountability now. Staff in informal leadership roles or being prepared for formal roles may be considered case-by-case in consultation with the sponsoring organization. The content assumes the participant is currently carrying the regulatory and team-accountability load that defines the level.

What happens at the end of 6 months?

Each participant receives a post-cohort 60-day follow-up session (individual, 60 minutes) at the 8-month mark. The sponsoring organization receives an aggregate post-cohort summary. Participants who want to continue in a peer structure have the option of a lower-intensity ongoing peer circle — scoped separately. There is no automatic renewal; continuity is the participant's and organization's choice.

Related Resources

Ready to Get Started?

Schedule a no-obligation consultation with IHS. We will discuss the clinical-leader tier you are trying to reach, the organizational conditions they are carrying, and whether this cohort is the right structure for your institution at this time.

Schedule a Free Discovery Session